European Respiratory Journal最新文献

筛选
英文 中文
"Targeting transforming growth factor-β receptors in pulmonary hypertension." Christophe Guignabert and Marc Humbert. Eur Respir J 2021; 57: 2002341.
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-12 Print Date: 2024-12-01 DOI: 10.1183/13993003.52341-2020
{"title":"\"Targeting transforming growth factor-β receptors in pulmonary hypertension.\" Christophe Guignabert and Marc Humbert. <i>Eur Respir J</i> 2021; 57: 2002341.","authors":"","doi":"10.1183/13993003.52341-2020","DOIUrl":"https://doi.org/10.1183/13993003.52341-2020","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"64 6","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142817727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of M. tuberculosis DNA in peripheral blood mononuclear cells of tuberculosis contacts does not associate with blood RNA signatures for incipient tuberculosis. 在肺结核接触者的 PBMC 中检测到结核杆菌 DNA 与初发肺结核的血液 RNA 标志无关。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-12 Print Date: 2024-12-01 DOI: 10.1183/13993003.00479-2024
Joshua Rosenheim, Markos Abebe, Mulugeta Belay, Begna Tulu, Dawit Tayachew, Metasebia Tegegn, Sidra Younis, David A Jolliffe, Abraham Aseffa, Gobena Ameni, Stephen T Reece, Mahdad Noursadeghi, Adrian R Martineau
{"title":"Detection of <i>M. tuberculosis</i> DNA in peripheral blood mononuclear cells of tuberculosis contacts does not associate with blood RNA signatures for incipient tuberculosis.","authors":"Joshua Rosenheim, Markos Abebe, Mulugeta Belay, Begna Tulu, Dawit Tayachew, Metasebia Tegegn, Sidra Younis, David A Jolliffe, Abraham Aseffa, Gobena Ameni, Stephen T Reece, Mahdad Noursadeghi, Adrian R Martineau","doi":"10.1183/13993003.00479-2024","DOIUrl":"10.1183/13993003.00479-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus. 肺炎球菌耗糖造成的微环境酸化促进了人体肺泡屏障的破坏和免疫抑制。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-12 Print Date: 2024-12-01 DOI: 10.1183/13993003.01983-2023
Diana Fatykhova, Verena N Fritsch, Keerthana Siebert, Karen Methling, Michael Lalk, Tobias Busche, Jörn Kalinowski, January Weiner, Dieter Beule, Wilhelm Bertrams, Thomas P Kohler, Sven Hammerschmidt, Anna Löwa, Mara Fischer, Maren Mieth, Katharina Hellwig, Doris Frey, Jens Neudecker, Jens C Rueckert, Mario Toennies, Torsten T Bauer, Mareike Graff, Hong-Linh Tran, Stephan Eggeling, Achim D Gruber, Haike Antelmann, Stefan Hippenstiel, Andreas C Hocke
{"title":"Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus.","authors":"Diana Fatykhova, Verena N Fritsch, Keerthana Siebert, Karen Methling, Michael Lalk, Tobias Busche, Jörn Kalinowski, January Weiner, Dieter Beule, Wilhelm Bertrams, Thomas P Kohler, Sven Hammerschmidt, Anna Löwa, Mara Fischer, Maren Mieth, Katharina Hellwig, Doris Frey, Jens Neudecker, Jens C Rueckert, Mario Toennies, Torsten T Bauer, Mareike Graff, Hong-Linh Tran, Stephan Eggeling, Achim D Gruber, Haike Antelmann, Stefan Hippenstiel, Andreas C Hocke","doi":"10.1183/13993003.01983-2023","DOIUrl":"10.1183/13993003.01983-2023","url":null,"abstract":"<p><p><i>Streptococcus pneumoniae</i> is the most common causative agent of community-acquired pneumonia worldwide. A key pathogenic mechanism that exacerbates severity of disease is the disruption of the alveolar-capillary barrier. However, the specific virulence mechanisms responsible for this in the human lung are not yet fully understood. In this study, we infected living human lung tissue with <i>Strep. pneumoniae</i> and observed a significant degradation of the central junctional proteins occludin and vascular endothelial cadherin, indicating barrier disruption. Surprisingly, neither pneumolysin, bacterial hydrogen peroxide nor pro-inflammatory activation were sufficient to cause this junctional degradation. Instead, pneumococcal infection led to a significant decrease of pH (∼6), resulting in the acidification of the alveolar microenvironment, which was linked to junctional degradation. Stabilising the pH at physiological levels during infection reversed this effect, even in a therapeutic-like approach. Further analysis of bacterial metabolites and RNA sequencing revealed that sugar consumption and subsequent lactate production were the major factors contributing to bacterially induced alveolar acidification, which also hindered the release of critical immune factors. Our findings highlight bacterial metabolite-induced acidification as an independent virulence mechanism for barrier disruption and inflammatory dysregulation in pneumonia. Thus, our data suggest that strictly monitoring and buffering alveolar pH during infections caused by fermentative bacteria could serve as an adjunctive therapeutic strategy for sustaining barrier integrity and immune response.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Viewpoint on WHO implementation guidance on tuberculosis infection prevention and control. 世界卫生组织结核病感染预防与控制实施指南透视。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-12 Print Date: 2024-12-01 DOI: 10.1183/13993003.00109-2024
Onno W Akkerman, Giovanni Battista Migliori, Dennis Falzon, Alberto L Garcia-Basteiro, Avinash Kanchar, Olha Konstantynovska, Fusun Oner Eyuboglu, Raquel Duarte
{"title":"Viewpoint on WHO implementation guidance on tuberculosis infection prevention and control.","authors":"Onno W Akkerman, Giovanni Battista Migliori, Dennis Falzon, Alberto L Garcia-Basteiro, Avinash Kanchar, Olha Konstantynovska, Fusun Oner Eyuboglu, Raquel Duarte","doi":"10.1183/13993003.00109-2024","DOIUrl":"10.1183/13993003.00109-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is there a kindling effect in COPD exacerbations?
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-12 Print Date: 2024-12-01 DOI: 10.1183/13993003.01687-2024
Andriana I Papaioannou, Konstantinos Bartziokas
{"title":"Is there a kindling effect in COPD exacerbations?","authors":"Andriana I Papaioannou, Konstantinos Bartziokas","doi":"10.1183/13993003.01687-2024","DOIUrl":"https://doi.org/10.1183/13993003.01687-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"64 6","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142817730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on the European Respiratory Society pulmonary alveolar proteinosis guidelines.
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-05 Print Date: 2024-12-01 DOI: 10.1183/13993003.01633-2024
Ali Ataya, Elinor Lee
{"title":"Comment on the European Respiratory Society pulmonary alveolar proteinosis guidelines.","authors":"Ali Ataya, Elinor Lee","doi":"10.1183/13993003.01633-2024","DOIUrl":"https://doi.org/10.1183/13993003.01633-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"64 6","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous Positive Airway Pressure and Mandibular Advancement Splints: The CHOICE Multi-center Open-Label Randomized Clinical Trial.
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-05 DOI: 10.1183/13993003.01100-2024
Mona M Hamoda, Nelly Hyunh, Najib T Ayas, Pierre Rompre, Nick Bansback, Jean-François Masse, Patrick Arcache, Gilles Lavigne, Frederic Series, John A Fleetham, Fernanda R Almeida
{"title":"Continuous Positive Airway Pressure and Mandibular Advancement Splints: The CHOICE Multi-center Open-Label Randomized Clinical Trial.","authors":"Mona M Hamoda, Nelly Hyunh, Najib T Ayas, Pierre Rompre, Nick Bansback, Jean-François Masse, Patrick Arcache, Gilles Lavigne, Frederic Series, John A Fleetham, Fernanda R Almeida","doi":"10.1183/13993003.01100-2024","DOIUrl":"https://doi.org/10.1183/13993003.01100-2024","url":null,"abstract":"<p><strong>Rationale: </strong>Adherence to Continuous Positive Airway Pressure (CPAP) for Obstructive Sleep Apnoea (OSA) continues to be low with high termination rates. Alternative therapies to CPAP are needed.</p><p><strong>Objectives: </strong>To compare objective adherence to CPAP and Mandibular Advancement Splints (MAS) and to evaluate their effectiveness. Additionally, to identify treatment usage patterns and the clinical effectiveness of having both therapies.</p><p><strong>Methods: </strong>This multi-center, double-randomized, three-phase trial (titration/cross-over/observation) was conducted at three Canadian universities. Eligible participants were treatment-naïve with mild to severe OSA.</p><p><strong>Measurements and main results: </strong>Primary outcome was objectively measured adherence (hours/night) during cross-over phase. Secondary outcomes included efficacy during cross-over phase; adherence during observational phase; patient-centered outcomes, blood pressure and side-effects during cross-over and observational phases. Duration of cross-over and observational phases were 2.5 and 6 months respectively.Eighty-one participants were enrolled in the first randomization. Seventy-nine entered the adaptation/titration phase [mean age (sd); 52·3 (10·8) years, 58 males], 73 entered the cross-over phase (included in the intention-to-treat analysis) and 64 completed the observation phase. Mean objective adherence over 1-month, MAS showed higher adherence than CPAP, 6·0 <i>versus</i> 5·3 h/night (difference= 0·7 h/night, 95% CI: 0·3-1·2 h, p<0·001). Mean CPAP-MAS difference (95% CI) in efficacy of 10·4 (7·8-13) events/hour, p<0·001. During the observation phase 55% (35/64) of participants chose to alternate therapies. All treatments led to substantial improvement in patient-centered outcomes.</p><p><strong>Conclusions: </strong>Despite the higher efficacy of CPAP and higher adherence to MAS, both demonstrate comparable clinical effectiveness on patient-centered outcomes. Having both CPAP and MAS can improve long-term management of OSA.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142785094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-05 DOI: 10.1183/13993003.01603-2024
Dave Singh, Robert Stockley, Antonio Anzueto, Alvar Agusti, Jean Bourbeau, Bartolome R Celli, Gerard J Criner, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Obianuju B Ozoh, Alberto Papi, Ian Pavord, Nicolas Roche, Sandeep Salvi, Don D Sin, Thierry Troosters, Jadwiga Wedzicha, Jinping Zheng, Claus Volgelmeier, David Halpin
{"title":"GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.","authors":"Dave Singh, Robert Stockley, Antonio Anzueto, Alvar Agusti, Jean Bourbeau, Bartolome R Celli, Gerard J Criner, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca, Obianuju B Ozoh, Alberto Papi, Ian Pavord, Nicolas Roche, Sandeep Salvi, Don D Sin, Thierry Troosters, Jadwiga Wedzicha, Jinping Zheng, Claus Volgelmeier, David Halpin","doi":"10.1183/13993003.01603-2024","DOIUrl":"https://doi.org/10.1183/13993003.01603-2024","url":null,"abstract":"<p><p>The Global initiative for chronic Obstructive Lung Disease (GOLD) report states that the diagnosis of chronic obstructive pulmonary disease (COPD) should be considered in individuals with chronic respiratory symptoms and / or exposure to risk factors. Forced spirometry demonstrating airflow obstruction after bronchodilation is required to confirm the diagnosis using a threshold of forced expiratory volume in 1 s (FEV<sub>1</sub>) / forced vital capacity (FVC) ratio<0.7. This GOLD Science Committee review weighs the evidence for using pre- or post-bronchodilator (BD) spirometry to diagnose COPD.Cohort studies have shown that pre- and post-BD spirometry give concordant diagnostic results in most cases, although the prevalence of COPD is up to 36% lower with post-BD values. Discordant results may occur in \"volume\" or \"flow\" responders. Volume responders have reduced FVC due to gas trapping causing FEV<sub>1</sub>/ FVC ratio >0.7 pre-BD, but a volume response occurs post-BD with a greater improvement in FVC relative to FEV<sub>1</sub> decreasing the ratio to <0.7. Flow responders show a greater FEV<sub>1</sub> improvement relative to FVC which may increase FEV<sub>1</sub>/ FVC from <0.7 pre-BD to >0.7 post-BD; these individuals have an increased likelihood of developing post-BD obstruction during follow up and require monitoring longitudinally.GOLD 2025 recommends using pre-BD spirometry to rule out COPD and post-BD measurements to confirm the diagnosis. This will reduce clinical workload. Post-BD results close to the threshold should be repeated to ensure a correct diagnosis is made. Post-BD measurements ensure that volume responders are not overlooked and limit COPD overdiagnosis.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of an emphysema-specific ATII cell: a step towards understanding impaired lung regeneration in COPD?
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-05 Print Date: 2024-12-01 DOI: 10.1183/13993003.01741-2024
Yiling Guo, Louise E Donnelly
{"title":"Identification of an emphysema-specific ATII cell: a step towards understanding impaired lung regeneration in COPD?","authors":"Yiling Guo, Louise E Donnelly","doi":"10.1183/13993003.01741-2024","DOIUrl":"https://doi.org/10.1183/13993003.01741-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"64 6","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophils, mucus plugs and clinical outcomes: findings from two COPD cohorts. 嗜酸性粒细胞、粘液栓和临床结果:两个慢性阻塞性肺疾病队列的研究结果。
IF 16.6 1区 医学
European Respiratory Journal Pub Date : 2024-12-05 Print Date: 2024-12-01 DOI: 10.1183/13993003.01005-2024
Alejandro A Diaz, Scott Grumley, Andrew Yen, Sushilkumar Sonavane, Rim Elalami, Maya Abdalla, Kangjin Kim, Pietro Nardelli, Sharon Brouha, Padma P Manapragada, Mostafa Abozeed, Muhammad Usman Aziz, Mohd Zahid, Hrudaya P Nath, Wei Wang, James C Ross, Carrie L Pistenmaa, Raul San José Estépar, Michael H Cho
{"title":"Eosinophils, mucus plugs and clinical outcomes: findings from two COPD cohorts.","authors":"Alejandro A Diaz, Scott Grumley, Andrew Yen, Sushilkumar Sonavane, Rim Elalami, Maya Abdalla, Kangjin Kim, Pietro Nardelli, Sharon Brouha, Padma P Manapragada, Mostafa Abozeed, Muhammad Usman Aziz, Mohd Zahid, Hrudaya P Nath, Wei Wang, James C Ross, Carrie L Pistenmaa, Raul San José Estépar, Michael H Cho","doi":"10.1183/13993003.01005-2024","DOIUrl":"10.1183/13993003.01005-2024","url":null,"abstract":"","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信